Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Glucose Monitoring Oct 26 | 2020Lifescan Partners with Truepill to Expand eCommerce PresencePurchase Blast
$599
Posted in: Basal Insulin Oct 23 | 2020Biocon CY Q3 '20 (FY Q2 '21) Earnings UpdatePurchase Blast
$599
Posted in: Other, SGLT2i Oct 23 | 2020FIDELIO Demonstrates 18% RRR; DAPA-CKD and EMPEROR-Reduced Sub-AnalysesPurchase Blast
$599
Posted in: Glucose Monitoring, Other Oct 21 | 2020Abbott Q3 '20 Earnings Update; Novo Licenses Antibody Engineering Tech From ChugaiPurchase Blast
$599
Posted in: Other, SGLT2i Oct 20 | 2020New AZD9977 + Dapa Ph2b Trial in HF+CKD (MIRACLE)Purchase Blast
$599
Posted in: Basal Insulin, Glucose Monitoring, SGLT2i Oct 16 | 2020DAPA-HF Receives Positive CHMP Opinion; Oramed Oral Insulin Ph3 T2DM Development Update; Livongo Partners with GuideWellPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Oct 15 | 2020BI Partners With Yale for HF Digital Solutions Trial; New Lilly Lyumjev T1DM TIR Study; Roche Q3 '20 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, SGLT2i Oct 13 | 2020Dario Included in Vitality's Gateway Flex Program; J&J Q3 '20 Earnings UpdatePurchase Blast
$599
Posted in: Bolus Insulin, GLP-1RA, SGLT2i Oct 12 | 2020DAPA-HF CHMP Opinion This Week?; October 12-15 CHMP AgendaPurchase Blast
$599
Posted in: Other, SGLT2i Oct 09 | 2020First Results for Bayer's FIDELIO @ Kidney Week; ASN High-impact Trials ReleasedPurchase Blast
$599
Posted in: GLP-1RA, Insulin Delivery Oct 09 | 2020Novo Launches the First Rybelsus Video DTC campaign; New Omnipod DTC from InsuletPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Oct 08 | 2020Livongo Partners with Fresenius for CKD; New CGM/AID Hospital GuidelinesPurchase Blast
$599
Posted in: Other Oct 08 | 2020GALACTIC-HF Results Disappoint; Omecamtiv Approval, but Utility is QuestionablePurchase Blast
$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery, Other Oct 07 | 2020Lilly and Dexcom Partner to Promote Lyumjev and G6 CGM; Omar Ishrak to Retire from Medtronic; Patia BioPharma and Precision Diabetes Partner for Diabetes Diagnostics; Capillary Bio Receives $1.5M Loan from HelmsleyPurchase Blast
$599
Posted in: Other, SGLT2i Oct 06 | 2020Sotagliflozin, Finerenone, and Omecamtiv CVOTs @ AHA 2020Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, SGLT2i Oct 05 | 2020Senseonics Files 180-Day Implantable CGM sPMA; Beyond Type 1 Launches Insulin Affordability Resource; KDIGO Releases New 2020 T2DM+CKD GuidelinesPurchase Blast
$599
Posted in: SGLT2i Oct 02 | 2020Farxiga Receives Breakthrough Therapy Designation for CKDPurchase Blast
$599
Posted in: Allogeneic, BCMA, CAR-T, CD19 Oct 02 | 2020Precision Biosciences Highlights First Patient Dosed with BCMA CAR-T PBCAR269A; PBCAR0191 Clinical Updates Delayed to YE; Q2 2020 Earnings SummaryPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
